Apyx Medical (APYX) vs Nyxoah SA (NYXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apyx Medical (APYX) has outperformed Nyxoah SA (NYXH) over the past year, losing 17.8% versus a loss of 77.9%. Over five years, APYX leads with a -82.1% price change compared with -94.7% for NYXH. Nyxoah SA is the larger company by market cap ($139.5 million vs $103.2 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | NYXH |
|---|---|---|
| Share price | $2.45 | $1.37 |
| Market cap | $103.20M | $139.52M |
| 1-day change | +3.81% | +1.48% |
| YTD return | -32.57% | -70.65% |
| 1-year return | -17.77% | -77.87% |
| 5-year return | -82.05% | -94.71% |
| EPS (TTM) | $-0.20 | $-2.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.08 | $6.88 |
| 52-week low | $2.32 | $1.26 |
| Distance from 52-week high | -51.77% | -80.07% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +165.31% | +206.57% |
| Average volume | 127.72K | 275.85K |
| Shares outstanding | 42.12M | 101.84M |
| Employees | 205 | 153 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- APYX has outperformed NYXH by 60.1 percentage points over the past year.
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Health Care · Medical/Dental Instruments · 205 employees
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
APYX vs NYXH FAQ
Which is bigger, Apyx Medical or Nyxoah SA?
Nyxoah SA (NYXH) is larger, with a market capitalization of $139.52M compared with $103.20M for Apyx Medical (APYX).
Which stock has performed better over the past year, APYX or NYXH?
APYX returned -17.77% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and Nyxoah SA in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.